Clinical trialNCT05131139UnknownInterventional

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

SponsorSenseonics, Inc.Enrollment350Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features. The purpose of this clinical investigation is to evaluate the accuracy of the Eversense 524 Continuous Glucose Monitoring System (Eversense 524 CGM System) and ROME CGM System with next generation feature enhancements compared to reference glucose measurements in adults 18 years of age and older with diabetes. The investigation will also evaluate safety of the Eversense 524 CGM System and ROME CGM System usage. Additionally, the safety and accuracy of the Eversense 524 CGM System will be evaluated in the pediatric population ages 14-17 with Type 1 Diabetes Mellitus.

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Amcr Institute Inc.
Escondido, California, United States
Recruiting
Rocky Mountain Diabetes Center, Llc. (rmdc)
Idaho Falls, Idaho, United States
David Liljenquist
Recruiting
Clinical Trials of Texas, Llc. (ctt)
San Antonio, Texas, United States
Douglas S Denham, DO
Recruiting
Rainier Clinical Research Center
Renton, Washington, United States
Ronald Brazg, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Oct 2021
Primary completion: 30 Mar 2025
Completion: 30 Sept 2025
Last update posted: 26 Apr 2023
Registered enrollment: 350
Registry id: NCT05131139

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.